The number of deals announced in the global healthcare sector (including pharmaceuticals and medical equipment) declined by 6.8% during the week ended 21 June 2020, compared to the previous week, according to GlobalData’s deals database.

Aurojyoti Bose, Lead Analyst at GlobalData, comments: “Although the healthcare sector has been relatively resilient compared to other sectors amid the COVID-19 outbreak, deal activity in the sector has been inconsistent over the last few weeks. The decline in deal activity during this week followed growth in the previous week.”

Deal activity has remained inconsistent across geographies since the COVID-19 outbreak. While activity decreased in key markets such as the US and China during the week ended 21 June, the UK and Canada witnessed growth.

Bose continues: “Mergers and acquisitions (M&A), equity offerings, venture financing and private equity deals volume decreased by 11.1%, 17.5%, 17.1% and 18.2%, respectively, during the week while the number of partnership deals increased by 2.2%.”